Skip to main content
Fig. 6 | Diabetology & Metabolic Syndrome

Fig. 6

From: Gradual increasing dyslipidemia in treatment-naive male patients with human immunodeficiency virus and treated with tenofovir plus lamivudine plus efavirenz for 3 years

Fig. 6

Long-term effect of baseline CD4+ T cell count on lipid metabolism parameters within 96 weeks after initial ART with TDF plus 3TC plus EFV in treatment-naive patients with HIV (n = 61; 26, 12, 23 cases in the <  200, 200 to 350, and > 350 groups, respectively). A TC level. B LDL-c level. C HDL-c level. D TG level. ART, active antiretroviral therapy. TDF, Tenofovir. 3TC, Lamivudine. EFV, Efavirenz. TC, total cholesterol. LDL-c, low-density lipoprotein cholesterol. HDL-c, high-density lipoprotein cholesterol. TG, triglyceride. One-way ANOVA was used to compare lipid metabolism parameters between three groups at the same time point, and Two-way ANOVA was used to compare lipid metabolism parameters between three groups from baseline to 96 weeks. Comparison between different time points and different CD4+ T cell count groups, *P < 0.05, ** P< 0.01, ****P < 0.0001

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us